Evidence map›Paper›PMID 30578782›Full record

ArticleGastroenterology2019

Constitutively Higher Level of GSTT2 in Esophageal Tissues From African Americans Protects Cells Against DNA Damage.

Daysha Ferrer-Torres, Derek J Nancarrow, Hannah Steinberg, Zhuwen Wang, Rork Kuick, Katherine M Weh, Ryan E Mills, Dipankar Ray, Paramita Ray, Jules Lin and 10 more

Abstract readComparative StudyMulticenter Study
In one paragraph

Article in Gastroenterology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Pathogenesis of Barrett's Esophagus: Evolving and Emerging Mechanisms.Gastrointestinal endoscopy clinics of North America · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 4 institutions in 1 country.

Daysha Ferrer-TorresDepartment of Surgery, Section of Thoracic Surgery, University of Michigan, Ann Arbor, Michigan.
Derek J NancarrowDepartment of Surgery, Section of Thoracic Surgery, University of Michigan, Ann Arbor, Michigan.
Hannah SteinbergDepartment of Surgery, Section of Thoracic Surgery, University of Michigan, Ann Arbor, Michigan.
Zhuwen WangDepartment of Surgery, Section of Thoracic Surgery, University of Michigan, Ann Arbor, Michigan.
Rork KuickDepartment of Biostatistics, University of Michigan, Ann Arbor, Michigan.
Katherine M WehDepartment of Surgery, Section of Thoracic Surgery, University of Michigan, Ann Arbor, Michigan.
Ryan E MillsDepartments of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan.
Dipankar RayDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.
Paramita RayDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.
Jules LinDepartment of Surgery, Section of Thoracic Surgery, University of Michigan, Ann Arbor, Michigan.
Andrew C ChangDepartment of Surgery, Section of Thoracic Surgery, University of Michigan, Ann Arbor, Michigan.
Rishindra M ReddyDepartment of Surgery, Section of Thoracic Surgery, University of Michigan, Ann Arbor, Michigan.
Mark B OrringerDepartment of Surgery, Section of Thoracic Surgery, University of Michigan, Ann Arbor, Michigan.
Marcia I CantoDepartment of Medicine, Gastroenterology and Hepatology, Johns Hopkins University, Baltimore, Maryland.
Nicholas J ShaheenDivision of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina.
Laura A KrestyDepartment of Surgery, Section of Thoracic Surgery, University of Michigan, Ann Arbor, Michigan.
Amitabh ChakDepartment of Medicine, Gastroenterology, Case Western Reserve University, Cleveland, Ohio.
Thomas D WangDivision of Gastroenterology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan.
Joel H RubensteinDivision of Gastroenterology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan.
David G BeerDepartment of Surgery, Section of Thoracic Surgery, University of Michigan, Ann Arbor, Michigan. Electronic address: dgbeer@umich.edu.
University of Michigan · USCase Western Reserve University · USJohns Hopkins University · USUniversity of North Carolina at Chapel Hill · US

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI THEODORE S LAWRENCE · 1988 to 2026
$178.2M
Targeting 15-PGDH in Colon Cancer Prognosis, Prediction, Treatment and PreventionP50CA150964 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI MARKOWITZ, SANFORD D. · 2011 to 2022
$24.6M
University of Michigan Center for Gastrointestinal ResearchP30DK034933 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI OWYANG, CHUNG · 1986 to 2021
$22.5M
The Cleveland Digestive Diseases Research Core Center (DDRCC)P30DK097948 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI Theresa Torres Pizarro · 2015 to 2026
$15.6M
Whole Exome Approaches for Esophageal Adenocarcinoma Susceptibility GenesU54CA163060 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI CHAK, AMITABH, GUDA, KISHORE · 2011 to 2022
$14.0M
Validation & Pathology CoreU54CA163059 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RUBENSTEIN, JOEL H, WANG, THOMAS D · 2011 to 2022
$12.1M
Training Program in Tumor MicroenvironmentT32CA009676 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Maria G Castro, Analisa Virginia DiFeo · 1992 to 2026
$7.3M
Inhibition of Reflux-Induced Esophageal Adenocarcinoma by ProanthocyanidinsR01CA158319 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KRESTY, LAURA A · 2012 to 2016
$1.6M
Identification of Cell Surface Markers for Risk Stratification of Barrett's Esophagus PatientsF31CA200113 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI FERRER-TORRES, DAYSHA · 2015 to 2016
$68k
NCI NIH HHS F31 CA200113NCI NIH HHS P30 CA046592NCI NIH HHS P50 CA150964NCI NIH HHS R01 CA158319NCI NIH HHS T32 CA009676NCI NIH HHS U54 CA163059NCI NIH HHS U54 CA163060NIDDK NIH HHS P30 DK034933NIDDK NIH HHS P30 DK097948
6 · The paper itself

Abstract

BACKGROUND &

aimsAfrican American and European American individuals have a similar prevalence of gastroesophageal reflux disease (GERD), yet esophageal adenocarcinoma (EAC) disproportionately affects European American individuals. We investigated whether the esophageal squamous mucosa of African American individuals has features that protect against GERD-induced damage, compared with European American individuals.

methodsWe performed transcriptional profile analysis of esophageal squamous mucosa tissues from 20 African American and 20 European American individuals (24 with no disease and 16 with Barrett's esophagus and/or EAC). We confirmed our findings in a cohort of 56 patients and analyzed DNA samples from patients to identify associated variants. Observations were validated using matched genomic sequence and expression data from lymphoblasts from the 1000 Genomes Project. A panel of esophageal samples from African American and European American subjects was used to confirm allele-related differences in protein levels. The esophageal squamous-derived cell line Het-1A and a rat esophagogastroduodenal anastomosis model for reflux-generated esophageal damage were used to investigate the effects of the DNA-damaging agent cumene-hydroperoxide (cum-OOH) and a chemopreventive cranberry proanthocyanidin (C-PAC) extract, respectively, on levels of protein and messenger RNA (mRNA).

resultsWe found significantly higher levels of glutathione S-transferase theta 2 (GSTT2) mRNA in squamous mucosa from African American compared with European American individuals and associated these with variants within the GSTT2 locus in African American individuals. We confirmed that 2 previously identified genomic variants at the GSTT2 locus, a 37-kb deletion and a 17-bp promoter duplication, reduce expression of GSTT2 in tissues from European American individuals. The nonduplicated 17-bp promoter was more common in tissue samples from populations of African descendant. GSTT2 protected Het-1A esophageal squamous cells from cum-OOH-induced DNA damage. Addition of C-PAC increased GSTT2 expression in Het-1A cells incubated with cum-OOH and in rats with reflux-induced esophageal damage. C-PAC also reduced levels of DNA damage in reflux-exposed rat esophagi, as observed by reduced levels of phospho-H2A histone family member X.

conclusionsWe found GSTT2 to protect esophageal squamous cells against DNA damage from genotoxic stress and that GSTT2 expression can be induced by C-PAC. Increased levels of GSTT2 in esophageal tissues of African American individuals might protect them from GERD-induced damage and contribute to the low incidence of EAC in this population.

Indexed as

DNA DamageAdenocarcinomaAnimalsBarrett EsophagusBlack or African AmericanDisease Models, AnimalEsophageal MucosaEsophageal NeoplasmsFemaleGastroesophageal RefluxGlutathione TransferaseHeLa CellsHistonesHumansIncidenceMalegamma-H2AX protein, ratGlutathione TransferaseGSTT2 protein, humanGstt2 protein, ratHistonesPhosphoproteinsBECranberry ProanthocyanidinsGlutathione TransferaseRacial Disparities

Identifiers

PMID30578782
PMCPMC6441633
OpenAlexW2905536856

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.